91AV

Introduction

Continued improvement in the nation's health depends upon the development of affordable and effective medicines and new therapeutic treatments. The last 20 years has seen the growth of a global healthcare industry based on human proteins produced in transformed mammalian cell lines, with a current market value of £30 billion/year. There is now an opportunity to replicate this growth in new industries using human stem cells in pharmaceutical and regenerative medicine applications. This meeting will focus on exploring the biological and engineering challenges lie ahead before cell based therapies can become an everyday reality.

Venue

The Penridge Suite,

The Penridge Suite,, 470 Bowes Road, London, N11 1NL, United Kingdom

Useful links

Organised by

Euroscicon

Contact information

Dr Shara Cohen
United Kingdom
Contact us by email

---